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Abstract: Background
Large scale collaborations are required to generate clinical evidence of traumatic brain
injury (TBI) treatments. Current evidence is limited and mostly originates from western
countries. China has a potential to generate strong evidence, but uncertainty exists
how comparable the baseline, treatment and outcome is to other settings. We aimed to
document the current care for TBI and its outcome in China by conducting a
prospective, multicentre Chinese TBI registry.
Methods
This prospective, multi-centre, longitudinal, observational study was conducted in 56
centres across China. It collected data of hospitalized patients with a clinical diagnosis
of TBI and indication for computerized tomography (CT) scanning. The primary
endpoint was survival on discharge. Prognostic analyses were applied to identify
predictors of mortality. Variations in mortality were compared between centres and
regions within China. Mortality was compared to expected mortality estimated by
CRASH basic model. The study was registered with ClinicalTrials.gov, number
NCT02210221.
Findings
From 22nd, Dec, 2014, to 1st, Aug, 2017, 13627 patients with TBI from 56 centers
were enrolled in the China CENTER-TBI registry. Data of 13138 patients from 52
hospitals in 22 provinces of China were analyzed. Most patients were male (9782
[74%]), with a median age of 48 (IQR: 33-61). The median Glasgow Coma Scale
(GCS) was 13 (IQR: 9-15) and major cause (6548 [50%]) of injury was traffic incident.
Overall hospital mortality was 4.8% (637), and in severe TBI 19.7% (552). Age, GCS,
Injury Severity Score, pupillary reflex, CT findings, hypoxia and hypotension showed
predictive value for mortality. Economic level and altitude of the regions were
correlated significantly with death. Variation in mortality existed between centres or
regions. The observed mortality was lower than expected (O/E ratio 0·49, 95% CI 0·45-
0·53).
Interpretation
The results show differences in mortality between centres and regions, which indicates
potential for identifying best practices in comparative effectiveness research. The risk
Powered by Editor ial Manager®  and ProduXion Manager®  from  Aries System s Corporat ion
factors identified in prognostic analyses may contribute to developing benchmarks for
assessing quality of care. The main strength of the study is the large study size and
wide coverage of centres across China. The main limitation is that outcome was
evaluated at discharge without follow up.
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Large scale collaborations are required to generate clinical evidence of traumatic brain injury 
(TBI) treatments. Current evidence is limited and mostly originates from western countries. 
China has a potential to generate strong evidence, but uncertainty exists how comparable the 
baseline, treatment and outcome is to other settings. We aimed to document the current care 
for TBI and its outcome in China by conducting a prospective, multicentre Chinese TBI registry. 
 
Methods 
This prospective, multi-centre, longitudinal, observational study was conducted in 56 centres 
across China. It collected data of hospitalized patients with a clinical diagnosis of TBI and 
indication for computerized tomography (CT) scanning. The primary endpoint was survival on 
discharge. Prognostic analyses were applied to identify predictors of mortality. Variations in 
mortality were compared between centres and regions within China. Mortality was compared 
to expected mortality estimated by CRASH basic model. The study was registered with 
ClinicalTrials.gov, number NCT02210221. 
 
Findings 
From 22nd, Dec, 2014, to 1st, Aug, 2017, 13627 patients with TBI from 56 centers were 
enrolled in the China CENTER-TBI registry. Data of 13138 patients from 52 hospitals in 22 
provinces of China were analyzed. Most patients were male (9782 [74%]), with a median age 
of 48 (IQR: 33-61). The median Glasgow Coma Scale (GCS) was 13 (IQR: 9-15) and major cause 
(6548 [50%]) of injury was traffic incident. Overall hospital mortality was 4.8% (637), and in 
severe TBI 19.7% (552). Age, GCS, Injury Severity Score, pupillary reflex, CT findings, hypoxia 
and hypotension showed predictive value for mortality. Economic level and altitude of the 
regions were correlated significantly with death. Variation in mortality existed between 




The results show differences in mortality between centres and regions, which indicates 
potential for identifying best practices in comparative effectiveness research. The risk factors 
identified in prognostic analyses may contribute to developing benchmarks for assessing 
quality of care. The main strength of the study is the large study size and wide coverage of 




No specific funding was provided for the China TBI registry. The coordinating centre received 




Research in context 
Evidence before this study 
We searched PubMed for registry studies on traumatic brain injury (TBI) that reported on early 
outcome and its prediction on 1st, Nov, 2019, using search terms “traumatic brain injury AND 
prognosis AND registry study” without language or country restrictions. We found 152 articles, 
from which we identified 31 studies that met the search criteria. These articles analyzed the 
outcome and prognostic factors of TBI patients, however, multi-centre clinical registry studies 
of TBI in Chinese patient populations are scarce, of older dates and mostly do not contain data 
recorded in formats compatible with standardized common data elements. As a consequence, 
comparisons to other registries are not straightforward and the literature data may not reflect 
the current patterns of traumatic brain injury in China, which have evolved along with the 
substantial development of the socioeconomic status in China. 
 
Added value of this study 
To our knowledge, this is the first large scale Registry study on TBI in China that has captured 
data in an identical format as in CENTER-TBI Europen Registry Study, which is a prospective, 
multi-centre, longitudinal, observational study in 22 countries across Europe and Israel. The 
results of this study portray the profile of Chinese TBI patients’ demographics, the prehospital 
management, the emergency and ICU treatment and the differences among Chinese centres. 
They present the real world of a big public health problem in a big country and provide a 
resource for future comparison between China and Europe.   
 
Implications of all the available evidence 
Heterogeneity of TBI and variation in healthcare may lead to different outcome of TBI patients 
in different centres or regions. Evidence from this study shows that patient characteristics, 
treatment approaches and mortality differ between centres, which provides opportunities for 
identification of best practices using comparative effectiveness research. Mortality was also 
related to regional features and economic level, which illustrates the need to tailor head 
trauma systems to better fit the situation in different areas. The results of this study, 
originating from China, a country with a large population, various geographical features, social 
development levels and with a huge burden of TBI, highlights the huge potential that 





Traumatic brain injury (TBI) presents a great challenge to public health worldwide. The 
heterogeneity of the disease, in terms of injury causes, mechanisms, approaches to treatment 
and outcome makes it a hugely complex problem compared to other diseases.1 Large scale 
studies are required to better characterize the disease, to generate evidence in support of 
treatment recommendations and to improve outcome.1 International collaborations offer the 
best potential to conduct such studies by increasing efficiency and generalizability and are 
strongly promoted by the International Initiative for Traumatic Brain Injury Research (InTBIR: 
https://intbir.nih.gov/), initiated as a collaboration of funding agencies.2,3  
 
China has a large potential to contribute to such evidence, but uncertainty exists how 
comparable patient characteristics, treatment and outcome are to other settings. Some large 
clinical registry studies of TBI in Chinese patient populations exist, but these are of older dates 
or from local areas, and may not reflect the current patterns of traumatic brain injury in China, 
which have evolved along with the substantial development of the socioeconomic status in 
China. Moreover, most data of these studies were not recorded in formats compatible with 
standardized common data elements, making it not straightforward to compare with other 
registries.4-6 In this study, we aimed to analyze epidemiological characteristics, management 
and outcome in an in-hospital cohort of TBI patients from centres in China. 
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Methods 
Study design and participants 
The China CENTER-TBI Registry is a prospective longitudinal observational study. It was 
modeled on the CENTER-TBI European Registry with an identical format for data collection and 
coding, and the study protocol and updated information was available on: www.center-
tbi.eu.7,8 Both studies included patients with a clinical diagnosis of TBI and indication for CT 
scanning. Data were prospectively collected from 56 Chinese neurosurgical centres in a 3-year 
period from 22nd, December, 2014 to 1st, August, 2017. 
 
Patients were differentiated by care path into two strata: admission stratum (admitted to the 
general ward), and ICU stratum (primarily admitted to the intensive care unit). Patients 
discharged directly from the Emergency Room were not included.  
 
Ethics statement: The study protocol was approved by the ethics committees of participating 
centres, who waived the need for informed consent as only routinely collected clinical data 
were recorded. 
 
Data collection, handling, and storage  
Clinical data of each patient was prospectively collected by one or more dedicated and trained 
physicians in each centre from patient medical records (paper or electronic) or personal 
interview. All data is in accordance with the medical records preserved in archives of each 
centre, which guarantees that all data is traceable. These variables included: demographics, 
medical history, injury characteristics, clinical and radiological severity upon arrival, 
emergency interventions, and care paths, including pre-hospital care system and transferals. 
Altitude and economic level were obtained from official government documents of National 
Bureau of Statistics. 
 
Data were collected using a web-based electronic case report form (eCRF) and managed by 
the QuesGen data management platform. Data were coded in accordance with the Common 
Data Elements (CDE) scheme (https://www.commondataelements.ninds.nih.gov). All study 
data were de-identified and stored securely in the European data space under the supervision 
of Karolinska Institute International Neuroinformatics Coordinating Facility (KI-INCF). 
Automated data validation checks were run on data entry and central inspectors (GG and JH) 
continuously reviewed and checked uploaded data for data entry errors. More details for data 
collection, handling and storage are listed in appendix, p1-2. 
 
Outcome 
The primary outcome was survival at discharge. In case of in-hospital death, time and cause 
of death were recorded. Variations in primary outcome between centers and provinces were 
analyzed and predictors for primary outcome identified. The secondary outcomes of this study 
included: transferals, and emergency interventions. 
 
Statistical analysis  
We excluded patients in whom information on discharge status or clinical severity (e.g. 
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Glasgow Coma Scale (GCS) and pupillary light reflex) was lacking (N=489). Missing values for 
other baseline characteristics were classified as "unknown". Continuous variables were 
reported as median and interquartile ranges (IQR), and categorical data as numbers and 
percentages. Patients were classified according to the GCS into severe (GCS 3-8), moderate 
(GCS 9-12) and mild TBI (GCS 13-15). 
 
Variations in primary outcome i.e. the hospital mortality between centers and provinces were 
analyzed in all 13138 patients using Logistic random effect models with a random intercept for 
center or province and adjustment for patient characteristics as fixed effects. Such models 
account for the fact that sample sizes per center may be small, introducing uncertainty, and 
for differences in patient populations between centers. Between-center variation was 
quantified with the median odds ratio (MOR), a measure based on the variance of the random 
effects. The MOR can be interpreted as the odds ratio for comparing two randomly selected 
centers. A MOR equal to one indicates no differences between centers. If there is considerable 
between-center variation, the MOR will be large. For example, a MOR of 2 for outcomes 
indicates that if two TBI patients with the same injury severity and characteristics presented 
to two random centers in our sample, one patient will have an over twofold probability of poor 
outcome.9,10  
 
Kaplan-Meier survival analysis was performed in 13098 patients with discharge or death time, 
with patients discharged alive treated as censored data at the time of discharge and 
subsequently multivariable mixed effect Cox proportional hazards regression was applied to 
identify the risk factors for survival. To assess for proportionality, we checked if the survival 
curves crossed for each variable. Variables included formed a two-level hierarchical structure, 
with patients at level one and centre at level two. At the patient level, we included 
demographic and injury characteristics, clinical severity, and radiological findings. At the 
centre level, we included altitude and economic level. Altitude level was classified into three 
categories according to the geographical features of China, i.e., below 100 meters, between 
100 and 500 meters and above 500 meters. The economic level was presented as GDP per 
capita of the province. 
 
Observed 14 day mortality was compared to expected mortality determined by the CRASH 
basic model,11 in 8351 patients with GCS <= 14 and all required covariates, and expressed as a 
ratio with 95% confidence intervals. 
 
In secondary outcomes analyses, variations in emergency interventions and care paths 
between centers and provinces were analyzed using Logistic random effect models in all 13138 
patients, and quantified with MOR. 
 
Statistical analyses were performed using R (Version 3·5·0) statistical software, with Studio 
(Version 1·1·447) used as the implementation Integrated Development Environment (IDE). 
Kaplan-Meier survival analysis was performed with “survfit” function in “survival” package 
(Version 2·44-1·1). Multivariable mixed effect Cox proportional hazards regression was 
performed with “coxme” function in “coxme” package (Version 2·2-16). The logistic random 
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effect regression models were fitted with the "glmer" function in "lme4" package (Version 1·1-
19). A two-tailed p-value of 0·05 or less was used to define statistical significance. The study 
was registered with ClinicalTrials.gov, number NCT02210221. 
 
Role of the funding source 
The funder of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all the 




From 22nd, Dec, 2014, to 1st, Aug, 2017, 13627 patients with TBI from 56 centers were 
registered in the China CENTER-TBI registry. Among them, 489 patients lack necessary 
information including discharge status, GCS and pupillary reflex, and data of 13138 patients 
from 52 hospitals in 22 provinces of China met eligibility criteria and could be analyzed (figure 
1, appendix p3 figure S1 and appendix p4 figure S2). 8317 were in the admission, 4747 in the 
ICU stratum and 74 lack stratum information. The median enrolment by centre was 137 
patients (IQR: 51- 346, appendix p3 figure S1). Recruiting centres varied in terms of 
geographical and economic features, with the altitude level ranging from 2 to 1892 meters 
and the GDP per capita ranging from 28 to 129 thousand yuan (4142 to 18749 US dollars). 
 
Characteristics of the patients enrolled, differentiated by stratum are presented in Table 1. The 
median age of all patients enrolled was 48 (IQR: 33-61) years, with 2217 (17%) > 65 years of 
age. Overall, males constituted 74% (n = 9782; ICU stratum 77%, n = 3661), and 95% of patients 
(n = 12539) were healthy or had only mild systemic diseases.  
 
Road traffic incidents were the major cause of injury, occurring in 50% (n = 6548) of patients, 
followed by accidental fall (n = 4363; 33%) and other injury mechanisms (n = 1714; 13%). 
Ground level falls occurred in 18% (n = 2321) and falls from height in 16% (n = 2042). However, 
differences in injury mechanism were noted between provinces (appendix p5 figure S3). 
 
We found that injury mechanisms differed by age (appendix p6 figure S4). Traffic incidents 
occurred more often in patients 18 to 65 years of age and decreased at higher ages, whilst 
ground level falls increased with age. Other injury mechanisms, mostly violence and suicide, 
peaked at ages 18-30. 
 
Most of the injuries occurred on the streets or highways (n = 7287; 55%), whilst 22% (n = 2912) 
of patients were injured at home. The composition of injury places differed between strata. 
Compared with the general ward, a higher percentage of patients in the ICU were injured on 
streets or highways (n = 2890; 61%) and fewer at home (n = 850; 18%) (table 1).  
 
Injuries causing TBI most commonly occurred between 9 am and 11 pm and peaked at 10 am 
(n = 1165; 8.9%), and patient arrival times showed similar trends (appendix p7 figure S5). At 
different arrival times, the causes of injury varied. Although road traffic incidents were the 
leading cause throughout the day, their proportion was relatively low in daytime. Conversely, 
the percentage of accidental falls, including ground level fall and fall from height, increased 
from 9 am to 7 pm (appendix p8 figure S6). 
 
Overall, the median GCS was 13 (IQR: 9-15), and 2804 (21%), 2930 (22%) and 7404 (56%) 
respectively were classified as severe, moderate and mild TBI (table 1 and appendix p9 figure 
S7). ISS score showed that 886 (6·7%) patients suffered from mild to moderate injury (ISS 1-8), 
4387 (33%) from serious injury (ISS 9-15), 4302 (33%) from severe injury (ISS 16-24) and 3563 
(27%) from critical injury (ISS 25-75). 3646 (28%) patients suffered from major extracranial 
injuries (AIS non-head >= 3). 1365 patients (10%) had an abnormal pupillary light reflex, 279 
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(2·1%) arrived with systemic hypotension, and 1257 (9·6%) with hypoxia. Injury severity varied 
between admission and ICU stratum: ICU patients had lower GCS, more severe TBI, higher ISS, 
more major extracranial injuries, more pupillary abnormalities, more hypotension, and more 
hypoxia upon arrival, compared to general ward patients (table 1). 
 
For primary outcome of 13138 patients, 637 (4·8%) patients died. Survival analysis estimated 
that 30-day survival rate was 94·5% (95%CI: 94·1% - 95·0%) and 90-day survival rate was 91·4% 
(95%CI: 90·1% - 92·7%) (figure 2). Of 2804 patients with severe TBI, 552 (19·7%) died. The 
leading cause of death was primary injury (n = 410, 64%), followed by secondary injury (n = 
153, 24%), complications (n = 32, 5·0%), and systemic injury (n = 24, 3·8%). Survival time to 
death was related to death cause, primary brain injuries tend to cause early-stage mortality 
while death after 15 days was mainly due to complications (figure 2).  
 
The CRASH basic model was fitted in 8351 patients with GCS <= 14 and all required covariates. 
The expected 14-day mortality was 1116 (13%), while 544 (6·5%) deaths within 14 days were 
observed (O/E ratio 0·49, 95% CI 0·45-0·53). Although overall mortality was lower than 
expected, the random effect model showed that odds of mortality varied substantially 
between provinces and hospitals (figure 3 and 4, appendix p13 table S1). 
 
Potential predictors for primary outcome, i.e. hospital mortality were identified in univariate 
analysis (appendix p14-15 table S2). All variables met Cox's proportional hazard assumption. 
Multivariable mixed effect Cox regression showed that age, GCS, ISS, pupillary reflex, hypoxia, 
systemic hypotension, compressed basal cistern, midline shift > 5mm, altitude > 500 meters, 
and GDP per capita were significantly associated with survival in all cohort TBI patients and 
also in severe TBI patients (figure 5, appendix p10 figure S8). 
 
The secondary outcomes included transferals and emergency interventions. A total of 3882 
patients (30%) were transferred from another hospital to the study centre, with substantial 
variations in secondary referral rates across provinces (appendix p11 figure S9). Secondary 
referrals were more frequent in the ICU stratum (n = 1691, 36%), compared to the admission 
stratum (n = 2173, 26%, appendix p16 table S3).  
 
A total of 2656 (20%) patients were emergently intubated, among which 154 received pre-
hospital intubation, and 2502 were intubated in the emergency room before admission to the 
general ward or ICU (appendix p16 table S3).  
 
Intracranial interventions, including ICP monitoring, external ventricular drainage (EVD), 
craniotomy and decompressive craniectomy were performed in 1509 (11%), 774 (5·9%), 2679 
(20%) and 2170 (17%) patients respectively (appendix p16 table S3), with substantial variation 
occurring between provinces and centers (appendix p11 figure S9 and appendix p13 table S1). 
Overall, only 208 patients (1·6%) received extracranial surgery. Differences in treatments were 
demonstrated between strata (appendix p16 table S3). 
 
Adjusting for center effects, it was shown that intracranial interventions, including ICP 
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monitoring, EVD, craniotomy, and decompressive craniectomy decreased mortality in patients 
with severe TBI and absent pupillary light reflex, but not in those with normal pupillary 






In this registry study, we present a contemporary picture of TBI in China. We found that, in 
China, adult patients in the ages 18-65 years old form the major part of the TBI population, 
that road traffic incidents remain the main cause of TBI and that most patients were in a 
normal healthy condition before the injury. Substantial differences in treatment and outcome 
were found between centres and regions. Overall, hospital mortality was 4·8%, which 
compares favorably to previous studies.5 
 
These data indicate that the baseline of TBI in China has remained stable, compared with 
published cohort data collected from 2004, or from 2008 to 2009.5,12 The proportion of severe 
TBI remains around 20%. In the present study, the median age is 48 years. These data indicate 
that unlike other regions, TBI in China remains a problem primarily of young and middle-aged 
adults, leading to huge losses in health and labor capacity.13-15 Nonetheless, 18% of patients 
admitted to the ICU had been injured at home, illustrating that accidents occurring in daily life 
at home may lead to a serious head injury, which is in line with the evidence from other 
studies.16 We anticipate that the changing demographics (ageing) of the population in China 
combined with further improvements in road traffic safety will lead to an increase of domestic 
injuries as cause of TBI in the near future, in particular in the elderly, thus following a trend 
observed in high income countries.1 
 
On presentation to the emergency department, 1257 (9·6%) patients suffered hypoxia leading 
to a high rate of emergency intubations. Combined with the low rate (1·2%, n = 154) of on-
scene intubations, these data indicate that the prehospital management of TBI patients needs 
further improvement regarding airway maintenance on-site or during transfer. Surgical 
interventions, including ICP device insertion, decompression, EVD and hematoma removal 
show clear therapeutic effects in patients with signs of brain herniation. The efficacy shown in 
this cohort likely reflects the greater severity of injuries, but from a clinical perspective it would 
be preferable to pre-emptively treat impending brain herniation, rather than to wait for its full 
development. Demonstrating effectiveness of these interventions in this cohort is of particular 
relevance given the lack of benefit reported in the overall populations of selected clinical 
trials.17-19 Identification of subgroups most likely to benefit from these interventions should be 
a priority, that can be addressed in comparative effectiveness research.20,21 
 
Of all patients admitted to the ICU with severe TBI, 64% did not receive an ICP device, thus 
implying that in many Chinese centres, clinical and image findings are still showing potential 
in driving treatments. The number of patients undergoing surgical treatments for extracranial 
injuries, was low in this cohort, likely reflecting admission policies of participating centres, 
where patients with more isolated TBI will be admitted to the neuro-intensive care unit, but 
patients with polytrauma to a general surgical ICU.  
  
The overall mortality of 4·8% and of 19·7% in patients with severe TBI compares favorably to 
published series from high income countries and was lower than expected from the CRASH 
basic model.11,22 The highest number of deaths occurred on the second day. Predictors of early 
mortality were in line with previous publications.23-25 A unique finding from this cohort was 
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that injury in higher altitude areas caused more death victims, and patients in areas of higher 
GDP had higher odds of mortality. Conceptually, these associations may be explained by centre 
effects, but this is rendered less likely by the random effects analysis which took centre into 
consideration. These results imply that the health policy to improve the care of TBI should also 
take into account the multiple geographic and developing levels, especially in China with 
variable natural, social, and economic status between provinces or regions. 
  
We found substantial differences in case-mix, treatment and outcome across Chinese centres. 
Variations in injury mechanism and process of care were found between provinces, which is 
in line with reports from other studies.8,26-28 Whilst the observed differences between 
provinces and centres offer potential to evaluate the performance of institute organization 
and professional behavior, they also indicate the need for initiatives to improve health care 
policy for TBI to take local aspects into consideration and to tailor head trauma systems to 
better fit the situation in different areas.  
 
The China TBI registry was modelled on the CENTER-TBI European registry with an identical 
format for data collection and coding. The intrinsic "twin" studies feature illustrates the 
benefits of standardized data collection according to a common format, and highlights the 
relevance of understanding the heterogeneous nature of TBI and its treatments in different 
continents. Compared to the CENTER-TBI registry in Europe, Chinese patients had higher 
severity (median GCS 14 in China vs. 15 in Europe for admission stratum; median GCS 10 in 
China vs. 12 in Europe for ICU stratum) and more patients received craniotomy (8% in China 
vs. 1.5% in Europe for admission stratum; 42% in China vs. 16% in Europe for ICU stratum).8 
Chinese dataset provides evidence that different approaches may be appropriate for different 
settings. This supports the potential for comparing different registries and collaborative 
studies.29,30  
 
The main strengths of our study are the large size of the cohort, the prospective recording of 
patient data and the multicentre organization for collecting data in China, covering 2/3 of all 
provinces, which increases representativeness of the data. The findings of this study provided 
a unique window to perceive the current profile of TBI in China, and the identical format to 
the CENTER-TBI registry in Europe permitted determination of similarities and differences 
between China and Europe. Some limitations should be recognized: First, we only analyzed 
data on patients admitted to 52 hospitals, not a nationwide population-based study. Second, 
data were collected from neuro-intensive care and neurosurgical units, and it should be 
recognized that patients with major extracranial injuries were underrepresented, as these are 
generally admitted to a general ICU in China. Third, outcome evaluation was limited to 
outcome on discharge and no information on long term complications and outcome collected. 
We consider it a priority for future studies in China to attempt to collect longer term outcomes. 
Despite these limitations, we consider our study to provide a representative picture of the 
current care for TBI across China, highlighting also differences in structure and processes of 
care, which provide both challenges and opportunities. 
 
In conclusion, we prospectively collected demographic, clinical, treatment and hospital 
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discharge data in a large cohort of patients with TBI in China. Despite observing substantial 
differences between centers or regions, mortality on discharge after adjustment for random 
effects and for case-mix and was better than expected according to the CRASH prognostic 
model. These data indicate that large scale collaborative studies between China and high 
income countries on TBI are feasible. The substantial differences between provinces and 
centres within China indicate the potential for comparative effectiveness research to explore 
best practices. Prognostic modelling confirmed the relevance of known predictors and 
identified new predictors including altitude and GDP. Clear therapeutic effects of third tier 
therapies were demonstrated in the most severely injured patients. Combined together, the 
results of this study indicate the feasibility of large scale collaborative studies including 
Chinese centres, inform policymaking for targeted TBI prevention and management, and 
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Figures and legends 
 
Figure 1: Study population and selection process 
Severe TBI patients: GCS 3-8, mild to moderate TBI patients: GCS 9-15. 
 
Figure 2: Survival analysis and death causes 
(A) Number of deaths on every single day after admission; (B) Kaplan-Meier curve for crude survival 
with 95% CI in the overall population within 90 days, showing that 30-day survival rate was 94.5% and 
90-day survival rate was 91.4%; (C) Density plot of each death cause over time, in which the area 
under each death causes curve is 1, showing the time distribution of each death causes. 
 
Figure 3: Variations in process of care for severe TBI patients between provinces 
The log odds of discharge mortality per province compared with the overall average, showing the 
variations in mortality rate across China. The analyses were adjusted for baseline characteristics, clinical 
severity and CT result, and may reflect true differences in mortality. 
 
Figure 4: Odds of mortality between centres 
(A) Variation of mortality between centres in all TBI patients. (B) Variation of mortality between centres 
in severe TBI patients. The estimates are the (adjusted) log odds ratios for each centre for mortality, 
compared to the average centre. For example, a log odds of 1 means an exp(1)=2.7 times higher odds 
of mortality in that centre compared to the average centre. It is demonstrated that odds of mortality 
varied significantly between centres. Purple ones had odds of mortality significantly below average and 
green above average. Size of the diamond reflected the number of patients recruited in each centre.  
 
Figure 5: Predictors for mortality in TBI patients 
Multivariable mixed effect Cox regression showed that age, GCS, ISS, pupillary reflex, hypoxia, 
systemic hypotension, compressed basal cistern, midline shift > 5mm, altitude > 500 meters, and GDP 
per capita were significantly associated with mortality in TBI patients. 
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Large scale collaborations are required to generate clinical evidence of traumatic brain injury 
(TBI) treatments. Current evidence is limited and mostly originates from western countries. 
China has a potential to generate strong evidence, but uncertainty exists how comparable the 
baseline, treatment and outcome is to other settings. We aimed to document the current care 
for TBI and its outcome in China by conducting a prospective, multicentre Chinese TBI registry. 
 
Methods 
This a prospective, multi-centre, longitudinal, observational study was conducted in 56 centres 
across China. It collected data of hospitalized patients with a clinical diagnosis of TBI and 
indication for computerized tomography (CT) scanning. The primary endpoint was survival on 
discharge. Prognostic analyses were applied to identify predictors of mortality. Variations in 
mortality were compared between centres and regions within China. Mortality was compared 
to expected mortality estimated by CRASH basic model. The study was registered with 
ClinicalTrials.gov, number NCT02210221. 
 
Findings 
From 22nd, Dec, 2014, to 1st, Aug, 2017, 13627 patients with TBI from 56 centers were 
enrolled in the China CENTER-TBI registry. Data of 13138 patients from 52 hospitals in 22 
provinces of China were analyzed. Most patients were male (9782 [74%]), with a median age 
of 48 (IQR: 33-61). The median Glasgow Coma Scale (GCS) was 13 (IQR: 9-15) and major cause 
(6548 [50%]) of injury was traffic incident. Overall hospital mortality was 4.8% (637), and in 
severe TBI 19.7% (552). Age, GCS, Injury Severity Score, pupillary reflex, CT findings, hypoxia 
and hypotension showed predictive value for mortality. Economic level and altitude of the 
regions were correlated significantly with death. Variation in mortality existed between 




The results show differences in mortality between centres and regions, which indicates 
potential for identifying best practices in comparative effectiveness research. The risk factors 
identified in prognostic analyses may contribute to developing benchmarks for assessing 
quality of care. The main strength of the study is the large study size and wide coverage of 




No specific funding was provided for the China TBI registry. The coordinating centre received 




Research in context 
Evidence before this study 
We searched PubMed for registry studies on traumatic brain injury (TBI) that reported on early 
outcome and its prediction on 1st, Nov, 2019, using search terms “traumatic brain injury AND 
prognosis AND registry study” without language or country restrictions. We found 152 articles, 
from which we identified 31 studies that met the search criteria. These articles analyzed the 
outcome and prognostic factors of TBI patients, however, multi-centre clinical registry studies 
of TBI in Chinese patient populations are scarce, of older dates and mostly do not contain data 
recorded in formats compatible with standardized common data elements. As a consequence, 
comparisons to other registries are not straightforward and the literature data may not reflect 
the current patterns of traumatic brain injury in China, which have evolved along with the 
substantial development of the socioeconomic status in China. 
 
Added value of this study 
To our knowledge, this is the first large scale Registry study on TBI in China that has captured 
data in an identical format as in CENTER-TBI Europen Registry Study, which is a prospective, 
multi-centre, longitudinal, observational study in 22 countries across Europe and Israel. The 
results of this study portray the profile of Chinese TBI patients’ demographics, the prehospital 
management, the emergency and ICU treatment and the differences among Chinese centres. 
They present the real world of a big public health problem in a big country and provide a 
resource for future comparison between China and Europe.   
 
Implications of all the available evidence 
Heterogeneity of TBI and variation in healthcare may lead to different outcome of TBI patients 
in different centres or regions. Evidence from this study shows that patient characteristics, 
treatment approaches and mortality differ between centres, which provides opportunities for 
identification of best practices using comparative effectiveness research. Mortality was also 
related to regional features and economic level, which illustrates the need to tailor head 
trauma systems to better fit the situation in different areas. The results of this study, 
originating from China, a country with a large population, various geographical features, social 
development levels and with a huge burden of TBI, highlights the huge potential that 





Traumatic brain injury (TBI) presents a great challenge to public health worldwide. The 
heterogeneity of the disease, in terms of injury causes, mechanisms, approaches to treatment 
and outcome makes it a hugely complex problem compared to other diseases.1 Large scale 
studies are required to better characterize the disease, to generate evidence in support of 
treatment recommendations and to improve outcome.1 International collaborations offer the 
best potential to conduct such studies by increasing efficiency and generalizability and are 
strongly promoted by the International Initiative for Traumatic Brain Injury Research (InTBIR: 
https://intbir.nih.gov/), initiated as a collaboration of funding agencies.2,3  
 
China has a large potential to contribute to such evidence, but uncertainty exists how 
comparable patient characteristics, treatment and outcome are to other settings. Some large 
clinical registry studies of TBI in Chinese patient populations exist, but these are of older dates 
or from local areas, and may not reflect the current patterns of traumatic brain injury in China, 
which have evolved along with the substantial development of the socioeconomic status in 
China. Moreover, most data of these studies were not recorded in formats compatible with 
standardized common data elements, making it not straightforward to compare with other 
registries.4-6 In this study, we aimed to analyze epidemiological characteristics, management 
and outcome in an in-hospital cohort of TBI patients from centres in China. 
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Methods 
Study design and participants 
The China CENTER-TBI Registry is a prospective longitudinal observational study. It was 
modeled on the CENTER-TBI European Registry with an identical format for data collection and 
coding, and the study protocol and updated information was available on: www.center-
tbi.eu.7,8 Both studies included patients with a clinical diagnosis of TBI and indication for CT 
scanning. Data were prospectively collected from 56 Chinese neurosurgical centres in a 3-year 
period from 22nd, December, 2014 to 1st, August, 2017. 
 
Patients were differentiated by care path into two strata: admission stratum (admitted to the 
general ward), and ICU stratum (primarily admitted to the intensive care unit). Patients 
discharged directly from the Emergency Room were not included.  
 
Ethics statement: The study protocol was approved by the ethics committees of participating 
centres, who waived the need for informed consent as only routinely collected clinical data 
were recorded. 
 
Data collection, handling, and storage  
Clinical data of each patient was prospectively collected by one or more dedicated and trained 
physicians in each centre from patient medical records (paper or electronic) or personal 
interview. All data is in accordance with the medical records preserved in archives of each 
centre, which guarantees that all data is traceable. These variables included: demographics, 
medical history, injury characteristics, clinical and radiological severity upon arrival, 
emergency interventions, and care paths, including pre-hospital care system and transferals. 
Altitude and economic level were obtained from official government documents of National 
Bureau of Statistics. 
 
Data were collected using a web-based electronic case report form (eCRF) and managed by 
the QuesGen data management platform. Data were coded in accordance with the Common 
Data Elements (CDE) scheme (https://www.commondataelements.ninds.nih.gov). All study 
data were de-identified and stored securely in the European data space under the supervision 
of Karolinska Institute International Neuroinformatics Coordinating Facility (KI-INCF). 
Automated data validation checks were run on data entry and central inspectors (GG and JH) 
continuously reviewed and checked uploaded data for data entry errors. More details for data 
collection, handling and storage are listed in appendix, p1-2. 
 
Outcome 
The primary outcome was survival at discharge. In case of in-hospital death, time and cause 
of death were recorded. Variations in primary outcome between centers and provinces were 
analyzedcompared and predictors for primary outcomee were identified. The secondary 
outcomes of this study included: transferals, and emergency interventions. 
 
Statistical analysis  
We excluded patients in whom information on discharge status or clinical severity (e.g. 
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Glasgow Coma Scale (GCS) and pupillary light reflex) was lacking (N=489). Missing values for 
other baseline characteristics were classified as "unknown". Continuous variables were 
reported as median and interquartile ranges (IQR), and categorical data as numbers and 
percentages. Patients were classified according to the GCS into severe (GCS 3-8), moderate 
(GCS 9-12) and mild TBI (GCS 13-15). 
 
Variations in primary outcome i.e. the hospital mortality between centers and provinces were 
analyzed in all 13138 patients using Logistic random effect models with a random intercept for 
center or province and adjustment for patient characteristics as fixed effects. Such models 
account for the fact that sample sizes per center may be small, introducing uncertainty, and 
for differences in patient populations between centers. Between-center variation was 
quantified with the median odds ratio (MOR), a measure based on the variance of the random 
effects. The MOR can be interpreted as the odds ratio for comparing two randomly selected 
centers. A MOR equal to one indicates no differences between centers. If there is considerable 
between-center variation, the MOR will be large. For example, a MOR of 2 for outcomes 
indicates that if two TBI patients with the same injury severity and characteristics presented 
to two random centers in our sample, one patient will have an over twofold probability of poor 
outcome.9,10  
 
Kaplan-Meier survival analysis was performed in 13098 patients with discharge or death time, 
with patients discharged alive treated as censored data at the time of discharge and 
subsequently multivariable mixed effect Cox proportional hazards regression was applied to 
identify the risk factors for survival. To assess for proportionality, we checked if the survival 
curves crossed for each variable. Variables included formed a two-level hierarchical structure, 
with patients at level one and centre at level two. At the patient level, we included 
demographic and injury characteristics, clinical severity, and radiological findings. At the 
centre level, we included altitude and economic level. Altitude level was classified into three 
categories according to the geographical features of China, i.e., below 100 meters, between 
100 and 500 meters and above 500 meters. The economic level was presented as GDP per 
capita of the province. 
 
Observed 14 day mortality was compared to expected mortality determined by the CRASH 
basic model,11 in 8351 patients with GCS <= 14 and all required covariates, and expressed as a 
ratio with 95% confidence intervals.In 8351 patients with GCS <= 14 and all required covariates, 
observed mortality within 14 days was compared to expected mortality determined by the 
CRASH basic model,11 and expressed as a ratio with 95% confidence intervals. 
 
In secondary outcomes analyses, vVariations in emergency interventions and care paths 
between centers and provinces were also analyzed using Logistic random effect models in all 
13138 patients, and quantified with MOR. 
 
Statistical analyses were performed using R (Version 3·5·0) statistical software, with Studio 
(Version 1·1·447) used as the implementation Integrated Development Environment (IDE). 
Kaplan-Meier survival analysis was performed with “survfit” function in “survival” package 
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(Version 2·44-1·1). The logistic random effect regression models were fitted with the "glmer" 
function in "lme4" package (Version 1·1-19). Multivariable mixed effect Cox proportional 
hazards regression was performed with “coxme” function in “coxme” package (Version 2·2-16). 
The logistic random effect regression models were fitted with the "glmer" function in "lme4" 
package (Version 1·1-19). A two-tailed p-value of 0·05 or less was used to define statistical 
significance. The study was registered with ClinicalTrials.gov, number NCT02210221. 
 
Role of the funding source 
The funder of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all the 




From 22nd, Dec, 2014, to 1st, Aug, 2017, 13627 patients with TBI from 56 centers were 
registered in the China CENTER-TBI registry. Among them, 489 patients lack necessary 
information including discharge status, GCS and pupillary reflex, and data of 13138 patients 
from 52 hospitals in 22 provinces of China met eligibility criteria and could be analyzed (figure 
1, appendix p3 figure S1 and appendix p4 figure S2). 8317 were in the admission, 4747 in the 
ICU stratum and 74 lack stratum information. The median enrolment by centre was 137 
patients (IQR: 51- 346, appendix p3 figure S1). Recruiting centres varied in terms of 
geographical and economic features, with the altitude level ranging from 2 to 1892 meters 
and the GDP per capita ranging from 28 to 129 thousand yuan (4142 to 18749 US dollars). 
 
Characteristics of the patients enrolled, differentiated by stratum are presented in Table 1. The 
median age of all patients enrolled was 48 (IQR: 33-61) years, with 2217 (17%) > 65 years of 
age. Overall, males constituted 74% (n = 9782; ICU stratum 77%, n = 3661), and 95% of patients 
(n = 12539) were healthy or had only mild systemic diseases.  
 
Road traffic incidents were the major cause of injury, occurring in 50% (n = 6548) of patients, 
followed by accidental fall (n = 4363; 33%) and other injury mechanisms (n = 1714; 13%). 
Ground level falls occurred in 18% (n = 2321) and falls from height in 16% (n = 2042). However, 
differences in injury mechanism were noted between provinces (appendix p5 figure S32). 
 
We found that injury mechanisms differed by age (appendix p65 figure S43). Traffic incidents 
occurred more often in patients 18 to 65 years of age and decreased at higher ages, whilst 
ground level falls increased with age. Other injury mechanisms, mostly violence and suicide, 
peaked at ages 18-30. 
 
Most of the injuries occurred on the streets or highways (n = 7287; 55%), whilst 22% (n = 2912) 
of patients were injured at home. The composition of injury places differed between strata. 
Compared with the general ward, a higher percentage of patients in the ICU were injured on 
streets or highways (n = 2890; 61%) and fewer at home (n = 850; 18%) (table 1).  
 
Injuries causing TBI most commonly occurred between 9 am and 11 pm and peaked at 10 am 
(n = 1165; 8.9%), and patient arrival times showed similar trends (appendix p76 figure S54). 
At different arrival times, the causes of injury varied. Although road traffic incidents were the 
leading cause throughout the day, their proportion was relatively low in daytime. Conversely, 
the percentage of accidental falls, including ground level fall and fall from height, increased 
from 9 am to 7 pm (appendix p87 figure S65). 
 
Overall, the median GCS was 13 (IQR: 9-15), and 2804 (21%), 2930 (22%) and 7404 (56%) 
respectively were classified as severe, moderate and mild TBI (table 1 and appendix p98 figure 
S76). ISS score showed that 886 (6·7%) patients suffered from mild to moderate injury (ISS 1-
8), 4387 (33%) from serious injury (ISS 9-15), 4302 (33%) from severe injury (ISS 16-24) and 
3563 (27%) from critical injury (ISS 25-75). 3646 (28%) patients suffered from major 
extracranial injuries (AIS non-head >= 3). 1365 patients (10%) had an abnormal pupillary light 
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reflex, 279 (2·1%) arrived with systemic hypotension, and 1257 (9·6%) with hypoxia. Injury 
severity varied between admission and ICU stratum: ICU patients had lower GCS, more severe 
TBI, higher ISS, more major extracranial injuries, more pupillary abnormalities, more 
hypotension, and more hypoxia upon arrival, compared to general ward patients (table 1). 
 
For primary outcome of 13138 patients, 637 (4·8%) patients died. Survival analysis estimated 
that 30-day survival rate was 94·5% (95%CI: 94·1% - 95·0%) and 90-day survival rate was 91·4% 
(95%CI: 90·1% - 92·7%) (appendix p9 figure S27). Of 2804 patients with severe TBI, 552 (19·7%) 
died. The leading cause of death was primary injury (n = 410, 64%), followed by secondary 
injury (n = 153, 24%), complications (n = 32, 5·0%), and systemic injury (n = 24, 3·8%). Survival 
time to death was related to death cause, primary brain injuries tend to cause early-stage 
mortality while death after 15 days was mainly due to complications (appendix p9 figure 
S7figure 2).  
 
The CRASH basic model was fitted in 8351 patients with GCS <= 14 and all required covariates. 
The expected 14-day mortality was 1116 (13%), while 544 (6·5%) deaths within 14 days were 
observed (O/E ratio 0·49, 95% CI 0·45-0·53). Although overall mortality was lower than 
expected, the random effect model showed that odds of mortality varied substantially 
significantly between provinces and hospitals (figure 3 A and 4, appendix p132 table S1). 
 
Potential predictors for primary outcome, i.e. hospital mortality were identified in univariate 
analysis (appendix p143-154 table S2). All variables met Cox's proportional hazard assumption. 
Multivariable mixed effect Cox regression showed that age, GCS, ISS, pupillary reflex, hypoxia, 
systemic hypotension, compressed basal cistern, midline shift > 5mm, altitude > 500 meters, 
and GDP per capita were significantly associated with survival in all cohort TBI patients and 
also in severe TBI patients (figure 5, appendix p10 figure S8). 
 
The secondary outcomes included transferals and emergency interventions. A total of 3882 
patients (30%) were transferred from another hospital to the study centre, with substantial 
variations in secondary referral rates across provinces (appendix p11 figure S9 3 B and 
appendix p15 table S3). Secondary referrals were more frequent in the ICU stratum (n = 1691, 
36%), compared to the admission stratum (n = 2173, 26%, appendix p16 table S3).  
 
A total of 2656 (20%) patients were emergently intubated, among which 154 received pre-
hospital intubation, and 2502 were intubated in the emergency room before admission to the 
general ward or ICU (appendix p165 table S3).  
 
Intracranial interventions, including ICP monitoring, external ventricular drainage (EVD), 
craniotomy and decompressive craniectomy were performed in 1509 (11%), 774 (5·9%), 2679 
(20%) and 2170 (17%) patients respectively (appendix p165 table S3), with substantial 
variation occurring between provinces and centers (appendix p11 figure S9figure 3 C-D and 
appendix p132 table S1). Overall, only 208 patients (1·6%) received extracranial surgery. 
Differences in treatments were demonstrated between strata (appendix p165 table S3). 
 
 11 
Adjusting for center effects, it was shown that intracranial interventions, including ICP 
monitoring, EVD, craniotomy, and decompressive craniectomy decreased mortality in patients 
with severe TBI and absent pupillary light reflex, but not in those with normal pupillary 






In this registry study, we present a contemporary picture of TBI in China. We found that, in 
China, adult patients in the ages 18-65 years old form the major part of the TBI population, 
that road traffic incidents remain the main cause of TBI and that most patients were in a 
normal healthy condition before the injury. Substantial differences in treatment and outcome 
were found between centres and regions. Overall, hospital mortality was 4·8%, which 
compares favorably to previous studies.5 
 
These data indicate that the baseline of TBI in China has remained stable, compared with 
published cohort data collected from 2004, or from 2008 to 2009.5,12 The proportion of severe 
TBI remains around 20%. In the present study, the median age is 48 years. These data indicate 
that unlike other regions, TBI in China remains a problem primarily of young and middle-aged 
adults, leading to huge losses in health and labor capacity.13-15 Nonetheless, 18% of patients 
admitted to the ICU had been injured at home, illustrating that accidents occurring in daily life 
at home may lead to a serious head injury, which is in line with the evidence from other 
studies.16 We anticipate that the changing demographics (ageing) of the population in China 
combined with further improvements in road traffic safety will lead to an increase of domestic 
injuries as cause of TBI in the near future, in particular in the elderly, thus following a trend 
observed in high income countries.1 
 
On presentation to the emergency department, 1257 (9·6%) patients suffered hypoxia leading 
to a high rate of emergency intubations. Combined with the low rate (1·2%, n = 154) of on-
scene intubations, these data indicate that the prehospital management of TBI patients needs 
further improvement regarding airway maintenance on-site or during transfer. Surgical 
interventions, including ICP device insertion, decompression, EVD and hematoma removal 
show clear therapeutic effects in patients with signs of brain herniation. The efficacy shown in 
this cohort likely reflects the greater severity of injuries, but from a clinical perspective it would 
be preferable to pre-emptively treat impending brain herniation, rather than to wait for its full 
development. Demonstrating effectiveness of these interventions in this cohort is of particular 
relevance given the lack of benefit reported in the overall populations of selected clinical 
trials.17-19 Identification of subgroups most likely to benefit from these interventions should be 
a priority, that can be addressed in comparative effectiveness research.20,21 
 
Of all patients admitted to the ICU with severe TBI, 64% did not receive an ICP device, thus 
implying that in many Chinese centres, clinical and image findings are still showing potential 
in driving treatments. The number of patients undergoing surgical treatments for extracranial 
injuries, was low in this cohort, likely reflecting admission policies of participating centres, 
where patients with more isolated TBI will be admitted to the neuro-intensive care unit, but 
patients with polytrauma to a general surgical ICU.  
  
The overall mortality of 4·8% and of 19·7% in patients with severe TBI compares favorably to 
published series from high income countries and was lower than expected from the CRASH 
basic model.11,22 The highest number of deaths occurred on the second day. Predictors of early 
mortality were in line with previous publications.23-25 A unique finding from this cohort was 
 13 
that injury in higher altitude areas caused more death victims, and patients in areas of higher 
GDP had higher odds of mortality. Conceptually, these associations may be explained by centre 
effects, but this is rendered less likely by the random effects analysis which took centre into 
consideration. These results imply that the health policy to improve the care of TBI should also 
take into account the multiple geographic and developing levels, especially in China with 
variable natural, social, and economic status between provinces or regions. 
  
We found substantial differences in case-mix, treatment and outcome across Chinese centres. 
Variations in injury mechanism and process of care were found between provinces, which is 
in line with reports from other studies.8,26-28 Whilst the observed differences between 
provinces and centres offer potential to evaluate the performance of institute organization 
and professional behavior, they also indicate the need for initiatives to improve health care 
policy for TBI to take local aspects into consideration and to tailor head trauma systems to 
better fit the situation in different areas.  
 
The China TBI registry was modelled on the CENTER-TBI European registry with an identical 
format for data collection and coding. The intrinsic "twin" studies feature illustrates the 
benefits of standardized data collection according to a common format, and highlights the 
relevance of understanding the heterogeneous nature of TBI and its treatments in different 
continents. Compared to the CENTER-TBI registry in Europe, Chinese patients had higher 
severity (median GCS 14 in China vs. 15 in Europe for admission stratum; median GCS 10 in 
China vs. 12 in Europe for ICU stratum) and more patients received craniotomy (8% in China 
vs. 1.5% in Europe for admission stratum; 42% in China vs. 16% in Europe for ICU stratum).8 
Chinese dataset provides evidence that different approaches may be appropriate for different 
settings. This supports the potential for comparing different registries and collaborative 
studies.29,30  
 
The main strengths of our study are the large size of the cohort, the prospective recording of 
patient data and the multicentre organization for collecting data in China, covering 2/3 of all 
provinces, which increases representativeness of the data. The findings of this study provided 
a unique window to perceive the current profile of TBI in China, and the identical format to 
the CENTER-TBI registry in Europe permitted determination of similarities and differences 
between China and Europe. Some limitations should be recognized: First, we only analyzed 
data on patients admitted to 52 hospitals, not a nationwide population-based study. Second, 
data were collected from neuro-intensive care and neurosurgical units, and it should be 
recognized that patients with major extracranial injuries were underrepresented, as these are 
generally admitted to a general ICU in China. Third, outcome evaluation was limited to 
outcome on discharge and no information on long term complications and outcome collected. 
We consider it a priority for future studies in China to attempt to collect longer term outcomes. 
Despite these limitations, we consider our study to provide a representative picture of the 
current care for TBI across China, highlighting also differences in structure and processes of 
care, which provide both challenges and opportunities. 
 
In conclusion, we prospectively collected demographic, clinical, treatment and hospital 
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discharge data in a large cohort of patients with TBI in China. Despite observing substantial 
differences between centers or regions, mortality on discharge after adjustment for random 
effects and for case-mix and was better than expected according to the CRASH prognostic 
model. These data indicate that large scale collaborative studies between China and high 
income countries on TBI are feasible. The substantial differences between provinces and 
centres within China indicate the potential for comparative effectiveness research to explore 
best practices. Prognostic modelling confirmed the relevance of known predictors and 
identified new predictors including altitude and GDP. Clear therapeutic effects of third tier 
therapies were demonstrated in the most severely injured patients. Combined together, the 
results of this study indicate the feasibility of large scale collaborative studies including 
Chinese centres, inform policymaking for targeted TBI prevention and management, and 
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Figures and legends 
 
Figure 1: Study population and selection process 
Severe TBI patients: GCS 3-8, mild to moderate TBI patients: GCS 9-15. 
 
Figure 2: Survival analysis and death causes 
(A) Number of deaths on every single day after admission; (B) Kaplan-Meier curve for crude survival 
with 95% CI in the overall population within 90 days, showing that 30-day survival rate was 94.5% and 
90-day survival rate was 91.4%; (C) Density plot of each death cause overwith time, in which the area 
under each death causes curve is 1, showing the time distribution of each death causes. 
 
Figure 2: Variation in injury mechanisms in 22 provinces in China 
Centres were grouped according to the provinces, and patients of centres in the same province were 
clustered for analysis. 
 
Figure 33: Variations in process of care for severe TBI patients between provinces 
(A) The log odds of discharge mortality per province compared with the overall average, showing the 
variations in mortality rate across China.; (B) The percentage of severe TBI patients referred from 
another hospital, per province, showing the variations in percentage of secondary referral across China; 
(C) The log odds of ICP monitoring per province compared with the overall average, showing the 
variations in ICP monitoring rate across China; (D) The log odds of external ventricular drainage (EVD) 
per province compared with the overall average, showing the variations in EVD rate across China; (E) 
The log odds of craniotomy per province compared with the overall average, showing the variations in 
craniotomy rate across China; (F) The log odds of decompression craniectomy (DC) per province 
compared with the overall average, showing the variations in DC rate across China. The interventions 
and Themortality analyses were adjusted for baseline characteristics, clinical severity and CT result, and 
may reflect true differences in mortalitypolicy. 
 
Figure 44: Odds of mortality between centres 
(A) Variation of mortality between centres in all TBI patients. (B) Variation of mortality between centres 
in severe TBI patients. The estimates are the (adjusted) log odds ratios for each centre for mortality, 
compared to the average centre. For example, a log odds of 1 means an exp(1)=2.7 times higher odds 
of mortality in that centre compared to the average centre. It is demonstrated that odds of mortality 
varied significantly between centres. Purple ones had odds of mortality significantly below average and 
green above average. Size of the diamond reflected the number of patients recruited in each centre.  
 
Figure 5: Predictors for mortality in TBI patients 
Multivariable mixed effect Cox regression showed that age, GCS, ISS, pupillary reflex, hypoxia, 
systemic hypotension, compressed basal cistern, midline shift > 5mm, altitude > 500 meters, and GDP 
per capita were significantly associated with mortality in TBI patients. 
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Reply to Editorial Comments
Point by Point Response to Editor: 
 
Editorial points to be addressed: 
1.    Abstract:  
a)    Based on the outcome section in the main text “The primary outcome was 
survival at discharge. In case of in-hospital death, time and cause of death were 
recorded. The secondary outcomes included: transferals, and emergency 
interventions.“ 
 
b)    Please only report the primary outcome (ie, survival at discharge) in the 
abstract. Remove all other analyses and outcomes. 
Reply: The secondary outcomes including transferals and emergency interventions 
were removed from the abstract section in an earlier version. Please specify any 
amendment if necessary.  
 
c)    The interpretation needs to be amended as secondary outcomes will need to 
be removed from here. 
Reply: The secondary outcomes including transferals and emergency interventions 
were not reported in the interpretation section. Please specify any amendment if 
necessary. 
 
d)    Move figure S7 (ie, the Kaplan-Meier curve) from the appendix to the main text 
as this was the primary outcome. Ensure that this figure is editable. Please add 95% 
CI to all time-to-event data and other data derived from Kaplan-Meier analyses. 
Please include number at risk (and, if available, number censored) in each group for 
each time point on any Kaplan-Meier curves. X axis should start at 0. 
Reply: Figure S7 was moved to the main text (Current Figure 2), with each individual 
part uploaded as eps file and a combined version was also uploaded. Part C contains 
transparency in layers which causes error in exporting as eps in R. Now it is first 
exported as pdf then converted to eps, and please inform us if you fail to edit it. 95% 
CI was added to the K-M plot and number at risk was reported. The current X axis 
starts at 0. 
 
2.    There are several other analyses and outcomes reported in the result section of 
the main text, however, these have not been described in the outcome section (eg, 
predictors for hospital mortality; variations in hospital mortality between centers 
and provinces) nor described as secondaty outcomes in the statitistcial analyses 
section. Please add and ensure that the order of the method section, statistical 
analyses and result section has the following order:  primary outcome, secondary 
outcomes, and finally any post-hoc or sensitivity analyses. This is not clear yet 
throughout the manuscript. 
Reply: Predictors and variations for primary outcome are now described in the 
outcome section and in the statistical analyses. The Methods and Results sections 
are now in the order above. The methods and results for secondary outcomes 
including transferals and emergency interventions were described after primary 
outcome. 
 
3.    „In 8351 patients with GCS <= 14“ – does it mean all TBI patients? Why not 
“mild to moderate TBI GCS of 15 or less”? Please clarify and adjust text if needed 
Reply: The observed mortality of this study was compared with the predicted 
mortality by CRASH model, which only fits for patients with Glasgow coma score 
(GCS) of 14 or less, so we selected patients who met the CRASH model criteria 
before comparing. We now clarify this in the Methods section. 
 
4.    Table 1:  
a)    Please add row for females 
Reply: We made adjustments accordingly. 
 
b)    Please add subheadings to guide the reader (eg, Demographic characteristics, 
Pre-injury health status and medical history, Cause of injury, Clinical presentation or 
whatever might be appropriate). This will help to compare it wit the European TBI 
Center study 
Reply: We made adjustments accordingly. 
 
5.    Some work is needed on the figures: only main results should be illustrated in 
the main text, all other plots need to be moved to the appendix 
Reply: Figure 2, which describes the injury mechanisms rather the primary outcome, 
is now moved to the appendix (Current Figure S3). Please let us know if there is any 
other figure that you think should be removed from the main text. 
 
6.    Figure 2 and 4 are not editable. Please submit editable figures 
Reply: All the figures uploaded are now editable. Current Figure 2 (Original Figure S7) 
is composed of 3 individual parts, and each part was uploaded as eps file. Part C 
contains transparency in layers which causes error in exporting as eps in R. Now it is 
first exported as pdf then converted to eps, and please inform us if you fail to edit it. 
 
7.    Figure 4: there are no centres mentioned in the graph – please provide. 
Reply: All the centre ID were provided in the graph now. 
 
8.    Figure 3: please only keep Figure 3 A and move all other graphs to the 
appendix; please rewrite the figure title to reflect the context better 
Reply: We have made adjustment accordingly. 
 
9.    Figure 5: Table 1:  
a)    Please add row for females 
Reply: In Cox regression, female was chosen as reference, and was explained in the 
graph. 
 
In summary, the signed statements we require are:  
* Authors' contribution and signatures 
* Signed conflict of interest statements for ALL authors 
Reply: We have uploaded the signatures and statements for all authors. 
 
Please also check whether you need to provide the following: 
* Signed copyright permissions for previously published material 
Reply: Not applicable. 
 
* Signed consent from individuals cited in the Acknowledgements 
Reply: We have uploaded Signed consent from all individuals cited in the 
Acknowledgements. 
 
* Signed consent for use of cited personal communications 
Reply: Not applicable. 
 
* Signed patient's consent and permission to publish (if not already submitted) 
Reply: Not applicable. 
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Table 1: Characteristics of 13138 patients enrolled in the China CENTER-TBI registry 
Variable Overall* 
(n = 13138) 
Admission  
(n = 8317) 
ICU  
(n = 4747) 
Demographic characteristics    
Age (median, (IQR)) 48 (33-61) 48 (31-61) 50 (35-61) 
  >65 2217 (17%) 1383 (16·6%) 826 (17.4%) 
Sex    
  Male 9782 (74%) 6068 (73%) 3661 (77%) 
Female 3356 (26%) 2249 (27%) 1086 (23%) 
Cause of injury    
Injury characteristics    
  Road traffic accident 6548 (50%) 3871 (47%) 2635 (56%) 
  Incidental fall 4363 (33%) 2833 (34%) 1513 (32%) 
      ground level fall 2321 (18%) 1635 (20%) 677 (14%) 
      fall from height 2042 (16%) 1198 (14%) 836 (18%) 
  Others (e.g. violence, suicide) 1714 (13%) 1215 (15%) 484 (10%) 
  Unknown 513 (3·9%) 398 (4·8%) 115 (2·4%) 
Injury place    
  Street/highway 7287 (55%) 4361 (52%) 2890 (61%) 
  Home 2912 (22%) 2044 (25%) 850 (18%) 
  Work/school 1056 (8·0%) 533 (6·4%) 519 (11%) 
  Sport 105 (0·8%) 74 (0·9%) 30 (0·6%) 
  Public location (e.g. bar, station, nightclub) 1702 (13%) 1248 (15%) 440 (9·3%) 
  Others 72 (0·5%) 56 (0·7%) 16 (0·3%) 
  Unknown 4 (0·0%) 1 (0·0%) 2 (0·0%) 
Pre-injury health status    
Pre-injury ASA-PS classification    
  ASA Ⅰ 10320 (79%) 6617 (80%) 3640 (77%) 
  ASA Ⅱ 2219 (17%) 1395 (17%) 813 (17%) 
  ASA Ⅲ 474 (3·6%) 266 (3·2%) 208 (4·4%) 
  ASA Ⅳ 78 (0·6%) 28 (0·3%) 50 (1·1%) 
  Unknown 47 (0·4%) 11 (0·1%) 36 (0·8%) 
Clinical presentation    
GCS sum score (median, (IQR)) 13 (9-15) 14 (12-15) 10 (6-13) 
  Mild (13-15) 7404 (56%) 5835 (70%) 1518 (32%) 
  Moderate (9-12) 2930 (22%) 1704 (20%) 1214 (26%) 
  Severe (3-8) 2804 (21%) 778 (9·4%) 2015 (42%) 
ISS score (median, (IQR)) 16 (10-25) 13 (9-19) 22 (16-29) 
  Mild to Moderate (1-8) 886 (6·7%) 808 (9·7%) 63 (1·3%) 
  Serious (9-15) 4387 (33%) 3947 (47%) 415 (8·7%) 
  Severe (16-24) 4302 (33%) 2217 (27%) 2068 (44%) 
  Critical (25-75) 3563 (27%) 1345 (16%) 2201 (46%) 
Major extracranial injury 3646 (28%) 1802 (22%) 1831 (39%) 
Table
Pupillary light reflex    
  One or both absent 1365 (10%) 353 (4·2%) 1006 (21%) 
Systemic hypotension 279 (2·1%) 120 (1·4%) 157 (3·3%) 
Hypoxia 1257 (9·6%) 479 (5·8%) 776 (16%) 
ASA-PS = The American Society of Anesthesiologists (ASA) physical status classification system, GCS = 
Glasgow Coma Scale, ISS = Injury Severity Score; Major extracranial injury: any AIS non-head >= 3; 




1. Supplementary Methods 
Procedures for database quality control: 
(1) Research training: 
1) The kick-off meeting of CENTER-TBI China Registry was held in 2014, Kunming, China to 
make sure that all participants understand the purpose and procedure of this trial. 
Professor Andrew Maas, the leader of CENTER-TBI project and Professor Mike Jarrett, the 
director of the database, were also invited to the meeting, which ensured that all centres 
followed the same study protocol as European Registry. 
2) During the meeting, the purpose and procedure of the trial was introduced, and the 
Chinese version of CRF was distributed to each centre, which was translated directly from 
the English version of CENTER-TBI Registry CRF by two experienced specialists of 
neurosurgery. 
3) Besides, all centres were trained to fill in the eCRFs by the director of the database at the 
kick-off meeting. 
(2) Data Collection: 
1) Clinical data was prospectively collected by one or more dedicated physicians in each centre 
according to patient medical records. These physicians had received dedicated training. All 
data is in accordance with the medical records preserved in archives of each centre, which 
guarantees that all data is traceable.  
2) Chinese version of CRF was applied for data collection, which was translated directly from 
the English version of CENTER-TBI Registry CRF by two experienced specialists of 
neurosurgery, to guarantee that all participants can understand the CRF well. 
3) The e-CRF had built-in data checks to detect errors and alert researchers to these. 
4) The CENTER-TBI China Registry has a data monitoring committee to oversee the study and 
specific central inspectors for data monitoring, who would check all the uploaded data on a 
continuous basis for data verification and progress report. 
5) Professor Andrew Maas, the leader of CENTER-TBI study in Europe, was invited to research 
meetings annually from 2014 to 2017 for China and European datasets quality assessment 
and comparison. 
(3) Data Storage:  
1) Prior to upload to the study database, acquired data was stored locally. All patients were 
allocated a random Global Unique Personal Identification number (GUPI), which was linked 
Appendix
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locally to hospital identifiers. Uploaded data was de-identified prior to upload. All data was 
kept confidential and anonymized beyond the initial stage of correlation for analysis. 
2) All de-identified electronic study data in the CENTER-TBI database was stored securely in 
the European data space under supervision of Karolinska Institute International 
Neuroinformatics Coordinating Facility (KI-INCF) for the duration of subject enrollment and 
follow-up and for a period afterwards for data analysis and preparation of publications.  
(4) Data Management: 
1) Clinical data was entered into eCRFs and managed by the QuesGen data management 
platform, which was developed in collaboration with KI-INCF. Data collection is based upon 
the CDEs. As data are entered into each form, the system will run data validation checks 
that include conditionally required data, validation across fields, and validation 
requirements based on subject type. If any validation check fails, the user is alerted 
immediately that the data do not meet quality assurance (QA) criteria and the issue can be 
addressed and corrected at that point.  
2) Together with QuesGen Systems, KI-INCF ensured that data standards are established for 
the data model (eg, conformity of field formats, field codes, and names to ensure 
consistency across all datasets). Any approved changes were fully documented with dataset 
updates to maintain data quality and accuracy. KI-INCF was responsible for importing 




2. Supplementary Figures 
Appendix Figure S1: Number of patients enrolled per centre differentiated by stratum 
 
Patients were recruited in 52 participating hospitals across China. The median enrolment by centre was 
137 patients. 63% patients recruited were in the admission stratum and 36% in the ICU stratum. 
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Appendix Figure S2: Centres participating in study 
 
13138 patients were recruited in 52 participating hospitals from 22 provinces of China. Each dot 
demonstrates one of the 52 centres, with color representing altitude level. Number of patients recruited 
in each province were represented by color of the province. 
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Appendix Figure S3: Variation in injury mechanisms in 22 provinces in China 
 
Centres were grouped according to the provinces, and patients of centres in the same province were 




Appendix Figure S4: Differences in injury mechanisms among different ages 
 
Injury mechanisms differed by age. Traffic incidents occurred more often in patients 18-65 years of age 
and decreased dramatically at higher ages. Ground level falls increased with age. Other injury 
mechanisms, mostly violence and suicide, peaked at 18-30 years of age. 
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Appendix Figure S5: Time distribution of injury and patient arrival 
 
TBI was most commonly seen between 9 am and 11 pm and peaked at 10 am, and patient arrival time 




Appendix Figure S6: Time distribution of different injury mechanisms 
 
The causes of injury varied at different patient arrival time. Although road traffic incidents were the 
leading cause throughout the whole day, their proportion was relatively low in the daytime. Conversely, 
the percentage of accidental falls, including ground level fall and fall from height, increased from 9 am 
to 7 pm. 
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Appendix Figure S7: Number of patients for each GCS sum score, differentiated by discharge status 
 
Median GCS was 13, and 2804 (21%), 2930 (22%) and 7404 (56%) respectively were classified as 




Appendix Figure S8: Predictors for mortality in severe TBI patients 
 
Multivariable analysis in severe TBI patients showed that the mortality predictors for severe cases 
included age, GCS, ISS, pupillary reflex, hypoxia, systemic hypotension, compressed basal cistern, 
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Appendix Figure S9: Variations in process of care for severe TBI patients between provinces 
 
(A) The percentage of severe TBI patients referred from another hospital, per province, showing the 
variations in percentage of secondary referral across China; (B) The log odds of ICP monitoring per 
province compared with the overall average, showing the variations in ICP monitoring rate across China; 
(C) The log odds of external ventricular drainage (EVD) per province compared with the overall average, 
showing the variations in EVD rate across China; (D) The log odds of craniotomy per province compared 
with the overall average, showing the variations in craniotomy rate across China; (E) The log odds of 
decompression craniectomy (DC) per province compared with the overall average, showing the 
variations in DC rate across China. The interventions analyses were adjusted for baseline characteristics, 


































Appendix Figure S10: Mortality rate of different treatments adjusted for center effects 
 
Intracranial intervention including ICP monitoring, EVD, craniotomy, and decompression craniectomy 
decreased mortality of severe TBI patients with abnormal pupil reflex, adjusting for center effects, but 
failed to show efficacy in light reflex normal group. 
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3. Supplementary Tables 
Appendix Table S1: Between-centre differences in China CENTER-TBI Registry 
 
Variation Within China 
MOR (95%CI) 
ICP Device Insertion 7·64 (4·77 – 12·98) 
External Ventricular Drainage 9·37 (4·77 – 18·63) 
Craniotomy 2·46 (1·90 – 3·17) 
Decompression Craniectomy 2·16 (1·74 – 2·70) 
Overall Mortality 2·00 (1·55 – 2·42) 
Severe Mortality 2·15 (1·62 – 2·71) 
Mortality and interventions were adjusted for age, gender, injury characteristics, clinical severity, vital 
signs and radiological findings. MOR: median odds ratio. 
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Appendix Table S2: Univariate analysis of predictors for hospital mortality in all 13138 patients 
Variable Survival(n = 12501) Dead(n = 637) P value* 
Age (median, (IQR)) 48 (32-61) 54 (44-68) <0·0001 




  Road traffic accident 6168 (49%) 380 (60%) 
<0·0001 
  Incidental fall 4186 (33%) 177 (28%) 
      ground level fall 2248 (18%) 73 (11%) 
      fall from height 1938 (16%) 104 (16%) 
  Others (e.g. violence, suicide) 1655 (13%) 59 (9·3%) 
  Unknown 492 (3·9%) 21 (3·3%) 
GCS Sum Score 14 (10-15) 4 (3-7) <0·0001 
ISS Score (median, (IQR))    
  Mild to Moderate (1-8) 884 (7·1%) 2 (0·3%) <0·0001 
  Serious (9-15) 4354 (35%) 33 (5·2%) 
  Severe (16-24) 4146 (33%) 156 (24%) 
  Critical (25-75) 3117 (25%) 446 (70%) 
Pupillary light reflex    
  One or both absent 982 (7·9%) 383 (60%) <0·0001 
Systemic hypotension 212 (1·7%) 67 (11%) <0·0001 
Hypoxia 1058 (8·5%) 199 (31%) <0·0001 
Compressed basal cistern 2970 (24%) 468 (73%) <0·0001 
Midline shift    
  No shift 7679 (61%) 109 (17%) 
<0·0001 
  Shift 0-4mm 3406 (27%) 172 (27%) 
  Shift ≥5mm 1133 (9·1%) 345 (54%) 
  Unknown 283 (2·3%) 11 (1·7%) 
tSAH 8244 (66%) 572 (90%) <0·0001 
Intracranial lesion 9879 (79%) 621 (97%) <0·0001 
Altitude    
  ≤100 8370 (67%) 385 (60%) 
<0·0001   >100 & ≤500 2414 (19%) 165 (26%) 
  >500 1717 (14%) 87 (14%) 
GDP per capita    
  <10000 6014 (48%) 353 (55%) 
<0·0001   10000-15000 2176 (17%) 64 (10%) 
  >15000 4311 (34%) 220 (35%) 
ASA-PS = The American Society of Anesthesiologists (ASA) physical status classification system, GCS = 
Glasgow Coma Scale, ISS = Injury Severity Score, tSAH = Traumatic Subarachnoid Hemorrha, GDP = Gross 
Domestic Product; Major extracranial injury: any AIS non-head >= 3; Systemic hypotension: systolic 
blood pressure <= 90mmHg; Hypoxia: SpO2 <= 95%. Potential predictors of death in all 13138 patients 
were age, gender, clinical severity, radiological findings, vital signs, and hospital-related variables 
including altitude and economic level. 
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Appendix Table S3: Characteristics of care pathways 
Variable Overall* 
(n = 13138) 
Admission  
(n = 8317) 
ICU  
(n = 4747) 
Referral    
  Primary referral 9249 (70%) 6144 (74%) 3053 (64%) 
  Secondary referral 3882 (30%) 2173 (26%) 1691 (36%) 
  Unknown 7 (0·0%) 0 (0·0%) 3 (0·1%) 
Emergency Intubation 2656 (20%) 855 (10%) 1791 (38%) 
  Pre-hospital Intubation 154 (1·2%) 25 (0·3%) 129 (2·7%) 
  Intubation at Emergency Department 2502 (19%) 830 (10%) 1662 (35%) 
ICP Sensor Insertion 1509 (11%) 172 (2·1%) 1334 (28%) 
ICP Sensor Insertion in severe patients 780 (28%) 55 (7·1%) 725 (36%) 
External Ventricular Drainage 774 (5·9%) 83 (1·0%) 690 (15%) 
External Ventricular Drainage in severe patients 368 (13%) 23 (3·0%) 345 (17%) 
Craniotomy for Haematoma 2679 (20%) 662 (8·0%) 2015 (42%) 
  Craniotomy for Haematoma in severe patients 1399 (50%) 253 (33%) 1145 (57%) 
Decompression Craniectomy 2170 (17%) 416 (5·0%) 1751 (37%) 
  Decompression Craniectomy in severe patients 1354 (48%) 199 (26%) 1153 (57%) 
Extracranial Surgery 208 (1·6%) 79 (0·9%) 127 (2·7%) 
Extracranial Surgery: limb fixation, thoracotomy, laparotomy and extraperitoneal pelvic packing. *74 
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